哈爾斯(002615.SZ):與浙江大學簽署技術開發合作合同 就智能水杯研發事宜達成合作
格隆匯6月26日丨哈爾斯(002615.SZ)公佈,近日,浙江哈爾斯真空器皿股份有限公司與浙江大學簽署《技術開發(合作)合同》,雙方就智能水杯研發事宜達成合作。
公司與浙江大學為推動產學研深度融合、探索技術成果轉化與產業驗證,於2023年6月25日簽訂《技術開發(合作)合同》,致力於聯合開發更加貼合健康生活理念、具有一定科技含量的智能水杯產品和解決方案。
雙方將在智能人體健康水杯系統研發領域,開展深入的交流與合作,嘗試以聯合研發創新的機制,豐富智能水杯的移動互聯功能,賦予其智慧健康新屬性。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.